30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Eran Broshy

Track

Insider profile

Performance

Overall performance
1.7
Performance over holding periods
1.7
30 days 90 days 120 days
Average return -9% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Magellan Health Inc Feb. 1, 2009 - May 1, 2019
Eran Broshy's trades of Theravance Biopharma Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-01 2025-11-26
PlS Planned sale
2,585 -27.1%
53.06
US$2,043,513 		2,585 -27.1% 53.06 US$2,043,513
2025-12-01 2025-11-26
PlS Planned sale
91,025 -3.5%
430.37
US$2,651,688 		91,025 -3.5% 430.37 US$2,651,688
2025-11-26 2025-11-26
PrS Proposed sale
1,124
229.17
US$2,123,248 		1,124 229.17 US$2,123,248
2025-11-13 2025-11-11
PlS Planned sale
14,000 -23.3%
18.50
US$259,000 		14,000 -23.3% 18.50 US$259,000
2025-11-13 2025-11-11
PlS Planned sale
15,500 -25.1%
17.00
US$263,500 		15,500 -25.1% 17.00 US$263,500
2025-11-13 2025-11-11
PlS Planned sale
29,500 -32.3%
18.50
US$545,750 		29,500 -32.3% 18.50 US$545,750
2025-11-12 2025-11-11
PrS Proposed sale
45,000
17.98
US$809,250 		45,000 17.98 US$809,250
2023-08-23 2023-08-22
US Certara Inc (CERT)
B Purchase
4,807 +50.3%
15.80
US$75,951 		4,807 +50.3% 15.80 US$75,951
2023-08-23 2023-08-21
US Certara Inc (CERT)
B Purchase
193 +2.1%
16.10
US$3,107 		193 +2.1% 16.10 US$3,107
2004-10-20 2004-10-18
S Sale
75,000 -51.6%
17.56
US$1,316,888 		75,000 -51.6% 17.56 US$1,316,888
2004-10-05 2004-10-01
S Sale
50,000 -25.6%
16.99
US$849,420 		50,000 -25.6% 16.99 US$849,420